Pharmaxess Consulting SRL
Pharmaxess Consulting reported total assets of 25,440 € at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Jun 2026).
The score of Pharmaxess Consulting shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmaxess Consulting's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jun 2026
- Year ended 31 Dec 2024filed on 17 Jul 2025
Pharmaxess Consulting's financial analysis
- Solvency37.3%sector median: 50.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmaxess Consulting
Pharmaxess Consulting's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1013.634.657
- VAT number
- BE1013634657
- Peppol
- Registered · 0208:1013634657 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 16 Sep 2024
- Registered office
- 4530 Villers-le-Bouillet
- Latest accounts
- 2025 · filed on 29 Jun 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
Pharmaxess Consulting (SRL) has been based in Villers-le-Bouillet since 2024, active in: business and other management consultancy activities. For 2025, it reports a net profit of 2,289 € and equity of 9,498 €; its revenue is not published. Its solvency stands at 37.3%, below the median of its sector (50.1%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pharmaxess Consulting
Companies in the same business, of comparable size and area, outside its group.
- MacMorDor Business and other management consultancy activities Liège · balance sheet 25,691 €
- Gemini Services & Solutions Business and other management consultancy activities Sint-Pieters-Leeuw · balance sheet 24,839 €
- Toromas Business and other management consultancy activities Holsbeek · balance sheet 26,072 €
- Industrieel en Commercieel Management Business and other management consultancy activities Brasschaat · balance sheet 24,785 €
- Ò Consult Business and other management consultancy activities Wezembeek-Oppem · balance sheet 24,755 €
- TB Advisory Business and other management consultancy activities Schaerbeek · balance sheet 26,237 €
- by R. Roosens Business and other management consultancy activities Antwerp · balance sheet 26,540 €
- Thisisit Business and other management consultancy activities Wortegem-Petegem · balance sheet 26,554 €
Frequently asked questions about Pharmaxess Consulting
What is the revenue of Pharmaxess Consulting?
Pharmaxess Consulting files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmaxess Consulting?
In Belgium, the VAT number is the company number prefixed with BE: BE1013634657 for Pharmaxess Consulting, if the company is VAT-registered. Its company number (CBE) is 1013.634.657.
Where is the registered office of Pharmaxess Consulting?
According to the CBE register, the registered office of Pharmaxess Consulting is in 4530 Villers-le-Bouillet.
What is the equity of Pharmaxess Consulting?
At the close of the 2025 financial year, the equity of Pharmaxess Consulting amounts to 9,498 €, a solvency of 37.3% of total assets.
Who manages Pharmaxess Consulting?
The register lists 1 active mandates at Pharmaxess Consulting. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmaxess Consulting
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →